rs73969684

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365536.1(SCN9A):​c.554G>A​(p.Arg185His) variant causes a missense change. The variant allele was found at a frequency of 0.0024 in 1,613,182 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R185C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0054 ( 6 hom., cov: 31)
Exomes 𝑓: 0.0021 ( 9 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

11
4
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:2B:13

Conservation

PhyloP100: 6.16

Publications

28 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: Cadd, Dann, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.01727277).
BP6
Variant 2-166305834-C-T is Benign according to our data. Variant chr2-166305834-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 157596.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00541 (821/151808) while in subpopulation AFR AF = 0.0138 (572/41408). AF 95% confidence interval is 0.0129. There are 6 homozygotes in GnomAd4. There are 386 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AD,SD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001365536.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN9A
NM_001365536.1
MANE Select
c.554G>Ap.Arg185His
missense
Exon 5 of 27NP_001352465.1Q15858-1
SCN9A
NM_002977.4
c.554G>Ap.Arg185His
missense
Exon 5 of 27NP_002968.2Q15858-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN9A
ENST00000642356.2
MANE Select
c.554G>Ap.Arg185His
missense
Exon 5 of 27ENSP00000495601.1Q15858-1
SCN9A
ENST00000303354.11
TSL:5
c.554G>Ap.Arg185His
missense
Exon 5 of 27ENSP00000304748.7Q15858-1
SCN9A
ENST00000409672.5
TSL:5
c.554G>Ap.Arg185His
missense
Exon 5 of 27ENSP00000386306.1Q15858-3

Frequencies

GnomAD3 genomes
AF:
0.00541
AC:
820
AN:
151690
Hom.:
6
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0138
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00559
Gnomad SAS
AF:
0.000832
Gnomad FIN
AF:
0.00218
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00221
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00280
AC:
698
AN:
249044
AF XY:
0.00261
show subpopulations
Gnomad AFR exome
AF:
0.0137
Gnomad AMR exome
AF:
0.00107
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00417
Gnomad FIN exome
AF:
0.00288
Gnomad NFE exome
AF:
0.00253
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00209
AC:
3049
AN:
1461374
Hom.:
9
Cov.:
33
AF XY:
0.00199
AC XY:
1450
AN XY:
726984
show subpopulations
African (AFR)
AF:
0.0130
AC:
434
AN:
33468
American (AMR)
AF:
0.00105
AC:
47
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00219
AC:
87
AN:
39686
South Asian (SAS)
AF:
0.000742
AC:
64
AN:
86240
European-Finnish (FIN)
AF:
0.00272
AC:
145
AN:
53400
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00185
AC:
2061
AN:
1111608
Other (OTH)
AF:
0.00345
AC:
208
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
160
320
481
641
801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00541
AC:
821
AN:
151808
Hom.:
6
Cov.:
31
AF XY:
0.00520
AC XY:
386
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.0138
AC:
572
AN:
41408
American (AMR)
AF:
0.00171
AC:
26
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00560
AC:
29
AN:
5176
South Asian (SAS)
AF:
0.000833
AC:
4
AN:
4804
European-Finnish (FIN)
AF:
0.00218
AC:
23
AN:
10546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00221
AC:
150
AN:
67898
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
40
80
119
159
199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00290
Hom.:
8
Bravo
AF:
0.00541
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.0135
AC:
50
ESP6500EA
AF:
0.00219
AC:
18
ExAC
AF:
0.00330
AC:
399
Asia WGS
AF:
0.00924
AC:
32
AN:
3478
EpiCase
AF:
0.00125
EpiControl
AF:
0.00130

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
3
not specified (3)
1
-
1
Paroxysmal extreme pain disorder (2)
1
-
1
Small fiber neuropathy (2)
-
-
1
Channelopathy-associated congenital insensitivity to pain, autosomal recessive (1)
-
-
1
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A (1)
-
-
1
Primary erythromelalgia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.074
T
BayesDel_noAF
Uncertain
0.13
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.95
D
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D
MetaRNN
Benign
0.017
T
MetaSVM
Uncertain
0.68
D
MutationAssessor
Pathogenic
3.8
H
PhyloP100
6.2
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-4.8
D
REVEL
Pathogenic
0.89
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.92
MVP
0.92
MPC
0.62
ClinPred
0.11
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.83
gMVP
0.91
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73969684; hg19: chr2-167162344; COSMIC: COSV57610109; COSMIC: COSV57610109; API